Leukemia Flashcards
1
Q
What is the target of Inotuzumab ozogamicin?
A
CD22
2
Q
Under what age should up-front ASCT be considered for aplastic anemia?
A
Under age 40
What is the target of Inotuzumab ozogamicin?
CD22
Under what age should up-front ASCT be considered for aplastic anemia?
Under age 40